TI
ADPT icon

Trexquant Investment’s Adaptive Biotechnologies ADPT Stock Holding History

Trexquant Investment’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.8M Buy
736,260
+164,676
+29% +$2.52M 0.09% 264
2026
Q1 		$7.93M Buy
571,584
+307,622
+117% +$4.9M 0.06% 461
2025
Q4 		$4.29M Sell
263,962
-402,954
-60% -$6.58M 0.04% 664
2025
Q3 		$9.98M Sell
666,916
-143,727
-18% -$1.75M 0.1% 283
2025
Q2 		$9.44M Buy
810,643
+525,862
+185% +$4.78M 0.11% 264
2025
Q1 		$2.12M Buy
284,781
+98,913
+53% +$760K 0.02% 850
2024
Q4 		$1.11M Buy
+185,868
New +$1.02M 0.01% 1069
2023
Q1 		– Sell
-123,841
Closed -$946K – 1400
2022
Q4 		$946K Buy
123,841
+108,133
+688% +$841K 0.03% 666
2022
Q3 		$112K Buy
+15,708
New +$148K ﹤0.01% 1276
2021
Q4 		– Sell
-9,989
Closed -$340K – 1265
2021
Q3 		$340K Buy
+9,989
New +$361K 0.03% 688

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Trexquant Investment's ADPT Position: Q2 2026 in Review

Trexquant Investment increased its Adaptive Biotechnologies (ADPT) stake by 29% in Q2 2026, buying an estimated $2.52M and bringing the position to 736,260 shares worth $15.8M. The position accounts for 0.09% of the portfolio, ranked #264.

Trexquant Investment first reported a position in ADPT in Q3 2021 and has held it in 10 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Trexquant Investment held 736,260 shares of Adaptive Biotechnologies worth $15.8M as of Q2 2026.
  • Trexquant Investment bought 164,676 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.52M.
  • Adaptive Biotechnologies made up 0.09% of Trexquant Investment's portfolio in Q2 2026, its #264 holding.
  • Trexquant Investment first reported a position in Adaptive Biotechnologies in Q3 2021 and has held it in 10 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.